Literature DB >> 25791039

Waist circumference as an independent risk factor for NODAT.

Ivana Dedinská1, Ľudovít Laca1, Juraj Miklušica1, Jaroslav Rosenberger2, Zuzana Žilinská3, Peter Galajda4, Marián Mokáň4.   

Abstract

BACKGROUND: New-onset diabetes mellitus after transplantation (NODAT) is a serious and frequent complication of solid organ transplantations. NODAT leads to 2-3 times higher cardiovascular morbidity and mortality. Visceral obesity is a key factor for diabetes mellitus type 2 and metabolic syndrome development, and is an independent risk factor for cardiovascular diseases.
MATERIAL AND METHODS: The series consisted of 167 patients after primary kidney transplantation from a dead donor (64 patients had developed NODAT), average age of the series was 46.1±11.6 years. We retrospectively examined waist circumference, body mass index, and weight gain in the 12th month after transplantation. We examined average level of triglycerides, cholesterol, and immunosuppression throughout the 12 monitored months.
RESULTS: Patients with NODAT were significantly older (P=0.004) and had greater waist circumference (P<0.0001) and higher average sirolimus level (P=0.0262). We identified the following independent risk factors for NODAT by using multivariate analysis: age at the time of transplantation above 50 years (HR=2.5038, [95% CI: 1.7179 to 3.6492], P<0.0001), waist circumference in men greater than 94 cm (HR=1.9492, [95% CI: 1.1697 to 3.2480], P=0.0104) and in women greater than 80 cm (HR=4.5018, [95% CI: 1.8669 to 10.8553], P=0.009). By using correlation coefficient we have proved that greater waist circumference was related to higher incidence of NODAT (r=0.1935, [95% CI: 0.01156 to 0.3630], P=0.0374). Graft survival (death censored) 12 months after kidney transplantation was 97.1% in the control group and 95.3% in the NODAT group (P=0.5381). Patient survival 12 months after kidney transplantation in the control group was 98.1% and in the NODAT group it was 96.9% (P=0.6113).
CONCLUSIONS: We identified waist circumference as an independent risk factor for NODAT in our analysis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25791039     DOI: 10.12659/AOT.892067

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  5 in total

1.  Calcineurin inhibitor-associated new-onset diabetes mellitus in chronic kidney disease treatment: a 4-year single-center cross-sectional study in China.

Authors:  Pan Kun-Ming; Chen Can; Xu Qing; Wu Wei; Lv Qian-Zhou; Li Xiao-Yu
Journal:  Eur J Clin Pharmacol       Date:  2021-01-23       Impact factor: 2.953

Review 2.  Kidney transplantation in obese patients.

Authors:  Minh-Ha Tran; Clarence E Foster; Kamyar Kalantar-Zadeh; Hirohito Ichii
Journal:  World J Transplant       Date:  2016-03-24

Review 3.  Obesity Management in Kidney Transplant Candidates: Current Paradigms and Gaps in Knowledge.

Authors:  Joanna H Lee; Elysia O McDonald; Meera N Harhay
Journal:  Adv Chronic Kidney Dis       Date:  2021-11       Impact factor: 3.620

4.  Correlation between CMV Infection and Post-transplantation New-onset Diabetes Mellitus.

Authors:  I Dedinská; Ľ Laca; J Miklušica; D Kantárová; P Galajda; M Mokáň
Journal:  Int J Organ Transplant Med       Date:  2016-08-01

5.  Cardiovascular effects of metabolic syndrome after transplantation: convergence of obesity and transplant-related factors.

Authors:  Kristen Sgambat; Sarah Clauss; Asha Moudgil
Journal:  Clin Kidney J       Date:  2017-07-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.